Correlation Between Pharmather Holdings and Enzolytics

Can any of the company-specific risk be diversified away by investing in both Pharmather Holdings and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmather Holdings and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmather Holdings and Enzolytics, you can compare the effects of market volatilities on Pharmather Holdings and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmather Holdings with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmather Holdings and Enzolytics.

Diversification Opportunities for Pharmather Holdings and Enzolytics

0.6

Correlation Coefficient

Pharmather Holdings  Enzolytics

Poor diversification

The 3 months correlation between Pharmather and Enzolytics is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Pharmather Holdings and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and Pharmather Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmather Holdings are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of Pharmather Holdings i.e., Pharmather Holdings and Enzolytics go up and down completely randomly.

Pair Corralation between Pharmather Holdings and Enzolytics

Assuming the 90 days horizon Pharmather Holdings is expected to under-perform the Enzolytics. But the otc stock apears to be less risky and, when comparing its historical volatility, Pharmather Holdings is 1.86 times less risky than Enzolytics. The otc stock trades about -0.03 of its potential returns per unit of risk. The Enzolytics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  0.19  in Enzolytics on September 13, 2024 and sell it today you would lose (0.05) from holding Enzolytics or give up 26.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Pharmather Holdings  vs.  Enzolytics

Pharmather Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmather Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Enzolytics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enzolytics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather weak basic indicators, Enzolytics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Pharmather Holdings and Enzolytics

The main advantage of trading using opposite Pharmather Holdings and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmather Holdings position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.

The idea behind Pharmather Holdings and Enzolytics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.